4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide,
cerdulatinib,
PRT062070,
Cerdulatinib,
1198300-79-6,
UNII-D1LXQ45S1O,
PRT062070,
D1LXQ45S1O,
Cerdulatinib (PRT062070),
PRT2070,
PRT 062070,
4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide,
4-(Cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide,
Cerdulatinib [INN],
4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide,
SCHEMBL736734,
GTPL8957,
CHEMBL4116008,
BCP10681,
EX-A2143,
PRT-2070,
AKOS026750510,
ZINC114483165,
CS-3329,
PRT-062070,
SB16931,
Cerdulatinib; PRT062070; PRT2070,
NCGC00386415-04,
4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide,
5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-,
AC-30243,
AK322445,
BC600583,
HY-15999,
B8023,
FT-0741914,
A14147,
Cerdulatinib(PRT-062070; PRT2070),